ZIM
MNTA

Zacks Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Zacks Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-41,848
Closed -$1.39M – 587
2020
Q2 		$1.39M Buy
+41,848
New +$1.33M 0.03% 249
2017
Q2 		– Sell
-10,066
Closed -$134K – 727
2017
Q1 		$134K Sell
10,066
-669
-6% -$10.5K ﹤0.01% 618
2016
Q4 		$162K Buy
+10,735
New +$142K ﹤0.01% 617

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Zacks Investment Management's MNTA Position: Q3 2020 in Review

Zacks Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 41,848 shares — an estimated $1.39M sold.

Zacks Investment Management first reported a position in MNTA in Q4 2016 and held it in 3 quarters. The position peaked at $1.39M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Zacks Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Zacks Investment Management sold 41,848 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.39M.
  • Zacks Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2016 and held it in 3 quarters.
  • Zacks Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $1.39M in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Zacks Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.